162 MEK162 (ARRY-162), a novel MEK 1/2 inhibitor, inhibits tumor growth regardless of KRas/Raf pathway mutations

S. Winski; D. Anderson; K. Bouhana; R. Impastato; R. Woessner; J. Zuzack; B. Tunquist; J. Garrus; T. Pheneger; P. Lee

作者S. Winski; D. Anderson; K. Bouhana; R. Impastato; R. Woessner; J. Zuzack; B. Tunquist; J. Garrus; T. Pheneger; P. Lee
卷第8卷
期第7期
文件大小56.05KB
发表时间2010
DOI10.1016/s1359-6349(10)71867-x

发现好书期刊，享受阅读乐趣